Detalles de la búsqueda
1.
Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.
Mol Ther
; 27(9): 1547-1557, 2019 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31303442
2.
Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
Cancer Res
; 67(8): 3583-93, 2007 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17440069
3.
Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development.
Cancer Res
; 66(4): 2059-66, 2006 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16489005
4.
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.
J Immunother Cancer
; 6(1): 119, 2018 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446007
5.
The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides.
Nucleic Acid Ther
; 27(5): 272-284, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28605247
6.
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.
Sci Transl Med
; 7(314): 314ra185, 2015 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-26582900
7.
Characterization of target mRNA reduction through in situ RNA hybridization in multiple organ systems following systemic antisense treatment in animals.
Nucleic Acid Ther
; 23(6): 369-78, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24161045
8.
The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult.
Cell Rep
; 2(1): 111-23, 2012 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22840402
Resultados
1 -
8
de 8
1
Próxima >
>>